CLINICAL_TRIALS
trial_result
· 2013-05-10
Clinical Trial Update: Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study [NA]
Summary
A feasibility study on hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer was terminated; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cantonal Hospital of St. Gallen | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Carcinoma | NA | Status: TERMINATED | Results posted: 2013-05-10